Cinryze SC (C1 esterase inhibitor [human] SC) / Takeda  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cinryze SC (C1 esterase inhibitor [human] SC) / Takeda
NCT01095497: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Completed
2
26
US
CINRYZE
Shire
Hereditary Angioedema
12/10
12/10
NCT01426763: A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

Completed
2
12
US
CINRYZE with rHuPH20, C1 esterase inhibitor (human), Recombinant human hyaluronidase
Shire, Halozyme Therapeutics
Hereditary Angioedema
11/11
11/11
NCT01756157 / 2012-000083-24: Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Completed
2
47
Europe, US
CINRYZE with rHuPH20, C1 esterase inhibitor (human), Recombinant human hyaluronidase
Shire
Hereditary Angioedema (HAE)
09/13
09/13

Download Options